Back to Agenda
Session 1: BIOSIMILARS IN THE EUROPEAN UNION – WHERE WE ARE AND WHERE WE GO
Session Chair(s)
Suzette Kox, MPharm
Senior Director International-Biosimilars Medicines Group
Medicines for Europe, Belgium
Steffen Thirstrup, MD, PhD
Chief Medical Officer
European Medicines Agency, Netherlands
Speaker(s)
Biosimilar Medicinal Products Working Party (BMWP) – Impact of experiences on guidelines
Christian Schneider, DrMed
PharmaLex, Denmark
Head of Biopharma Excellence and Chief Medical Officer (Biopharma)
Current Activities of the Biosimilar Medicinal Products Working Party (BMWP) and Outlook for the Future
Christian Schneider, DrMed
PharmaLex, Denmark
Head of Biopharma Excellence and Chief Medical Officer (Biopharma)
How do Biosimilars Evolve on the European Market
Per Troein, MBA, MSc
IQVIA, United Kingdom
VP Strategic Partners
Have an account?